Dr Richard Palmer: Chief Scientific Advisor - World leading surface scientist, nanotechnology expert and co-inventor of Inanovate’s platform technology base. Published > 230 papers; 11 patent applications. Head, Nanoscale Physics Laboratory, University of Birmingham; College Lecturer, Cambridge University; Royal Commission for the Exhibition of 1851 Research Fellow, Cavendish Laboratory; Visiting positions at Harvard University; Oxford University; Cornell University.

Dr. Brian Liu: Technology Development Advisor - Director of Translational Research in Urology, BWH, Harvard Medical School; Developed Inanovate’s patented auto-antibody assay process and panel of prostate cancer biomarkers, which were widely featured on CNN, in the Wall Street Journal, and in the Boston Globe; Recipient of over 40 research awards and prizes; Author of over 60 publications; Held various positions in major national societies, including: Treasurer, Society for Basic Urologic Research, and consultant for the NIH, the US Congressionally Directed Medical Research Programs, and the Department of Defense.

David Arslanian: Co-founder and Director – 10 yrs entrepreneurial, management and business development experience in financial services, business technology and biotechnology industries; MBA - Babson College; B.A. - University of Massachusetts; Babson College Board of Trustees.

Glen Wegner J.D. M.D: Technology and Business Development Advisor – 35 yrs experience in business, medicine, law, investment banking and public service. As an entrepreneurial founder and leader, Glen has been involved in all aspects of business from concept through IPO and SEC regulated public companies. Experience includes raising capital, marketing and selling through mergers, acquisitions and divestitures of businesses.

George Holmes: Business Development Advisor - 20 yrs senior management and entrepreneurial leadership experience in market driven technology firms focused on international business development in the US and Europe. Led organizations through change and growth as an interim CEO/COO; built culturally diverse organizations across multiple countries/regions. MBA - Tuck School of Business; BA - Boston University.

Dr. David Kerns: IP Strategy Advisor - Franklin & Mary Olin Distinguished Professor of Electrical Engineering at F. W. Olin College of Engineering; Previously co-founder & President of Insouth Microsystems, Inc; Owner of a variety of patents and inventions; Significant experience and expertise related to IP strategy in high tech companies.

Dr. Brian Warrington: Technology Commercialization Advisor - Previously: V.P. of Technology Development for GlaxoSmithKline, UK; Chairman of the INSIGHT High Throughput Technologies Faraday Partnership; Member of DTI National Strategic Advisory Group on Micro & Nanotechnology.